The Lancet Infectious Diseases, ISSN 1473-3099, 06/2018, Volume 18, Issue 6, pp. 590 - 591
Khalequ Zaman and colleagues provide helpful new information on the performance of serotype 2 monovalent oral poliovirus vaccine (mOPV2).2 This vaccine is held...
INFECTIOUS DISEASES | POLIOVIRUSES | Humans | Poliomyelitis - epidemiology | Disease Outbreaks - prevention & control | Poliovirus Vaccine, Inactivated | Poliovirus Vaccine, Oral | Poliovirus | Diabetes Mellitus, Type 2 - epidemiology | Poliomyelitis | Vaccines
INFECTIOUS DISEASES | POLIOVIRUSES | Humans | Poliomyelitis - epidemiology | Disease Outbreaks - prevention & control | Poliovirus Vaccine, Inactivated | Poliovirus Vaccine, Oral | Poliovirus | Diabetes Mellitus, Type 2 - epidemiology | Poliomyelitis | Vaccines
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 12, pp. 1310 - 1311
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S1473-3099(16)30371-1 Byline: Edward P K Parker, Nicholas C Grassly...
Infectious Disease | INFECTIOUS DISEASES | VACCINE | Epidemiology | Viruses | Immunoglobulins | Vaccines | Surveillance | Poliomyelitis | Mucous membrane
Infectious Disease | INFECTIOUS DISEASES | VACCINE | Epidemiology | Viruses | Immunoglobulins | Vaccines | Surveillance | Poliomyelitis | Mucous membrane
Journal Article
The Lancet Infectious Diseases, ISSN 1473-3099, 10/2019, Volume 19, Issue 10, pp. 1121 - 1128
The eradication of wild and vaccine-derived poliovirus requires the global withdrawal of oral poliovirus vaccines (OPVs) and replacement with inactivated...
IMMUNIZATION | INFECTIOUS DISEASES | IMMUNOGENICITY | IMPACT | MUCOSAL IMMUNITY | ANTIBODY | ENDGAME | Medicine, Experimental | Medical research | Infants | Vaccines | Analysis | World health | Schedules | Immunization | Mucosal immunity | Mucosa | Clinical trials | Systematic review | Immunity | Seroconversion | Meta-analysis | Studies | Heterogeneity | Immunogenicity | Intestine | Poliomyelitis | Data search | Serotypes | Immunity (humoral) | Paralysis | Bayesian analysis | Age
IMMUNIZATION | INFECTIOUS DISEASES | IMMUNOGENICITY | IMPACT | MUCOSAL IMMUNITY | ANTIBODY | ENDGAME | Medicine, Experimental | Medical research | Infants | Vaccines | Analysis | World health | Schedules | Immunization | Mucosal immunity | Mucosa | Clinical trials | Systematic review | Immunity | Seroconversion | Meta-analysis | Studies | Heterogeneity | Immunogenicity | Intestine | Poliomyelitis | Data search | Serotypes | Immunity (humoral) | Paralysis | Bayesian analysis | Age
Journal Article
Proceedings of the Royal Society B: Biological Sciences, ISSN 0962-8452, 10/2006, Volume 273, Issue 1600, pp. 2541 - 2550
disease outbreaks, endemic dynamics and persistence. Finally, a mathematical analysis of routine and pulse vaccination programmes for seasonal infections is...
Epidemics | Disease transmission | Infectious diseases | Disease models | Vaccination | Disease outbreaks | Measles | Infections | Stochastic models | Epidemiology | Seasons | Communicable diseases | UNITED-STATES | seasons | MASS VACCINATION | PERSISTENCE | INFLUENZA | communicable diseases | MEASLES | ELIMINATION | disease outbreaks | epidemiology | EVOLUTIONARY BIOLOGY | TRANSMISSION | MODELS | BIOLOGY | DYNAMICS | ECOLOGY | RECURRENT OUTBREAKS | vaccination | Communicable Diseases - epidemiology | Humans | Microbial Viability | Communicable Disease Control | Incidence | Endemic Diseases | Animals | Disease Outbreaks | Communicable Diseases - immunology | Disease Vectors | Child
Epidemics | Disease transmission | Infectious diseases | Disease models | Vaccination | Disease outbreaks | Measles | Infections | Stochastic models | Epidemiology | Seasons | Communicable diseases | UNITED-STATES | seasons | MASS VACCINATION | PERSISTENCE | INFLUENZA | communicable diseases | MEASLES | ELIMINATION | disease outbreaks | epidemiology | EVOLUTIONARY BIOLOGY | TRANSMISSION | MODELS | BIOLOGY | DYNAMICS | ECOLOGY | RECURRENT OUTBREAKS | vaccination | Communicable Diseases - epidemiology | Humans | Microbial Viability | Communicable Disease Control | Incidence | Endemic Diseases | Animals | Disease Outbreaks | Communicable Diseases - immunology | Disease Vectors | Child
Journal Article
Nature Reviews Microbiology, ISSN 1740-1526, 06/2008, Volume 6, Issue 6, pp. 477 - 487
Mathematical analysis and modelling is central to infectious disease epidemiology. Here, we provide an intuitive introduction to the process of disease...
POPULATION | RATES | COITAL ACT | PANDEMIC INFLUENZA | DYNAMICS | MICROBIOLOGY | NETWORK STRUCTURE | EPIDEMIC | SPREAD | HIV-1 TRANSMISSION | BAYESIAN-INFERENCE | Communicable Diseases - transmission | Communicable Diseases - epidemiology | Humans | Influenza, Human - epidemiology | Mathematics | Influenza, Human - transmission | Models, Statistical | Host-Pathogen Interactions | Stochastic Processes | Disease Outbreaks | Epidemiologic Methods | Models, Biological | Ecosystem | Usage | Mathematical analysis | Communicable diseases | Analysis | Distribution | Epidemiology | Risk factors | Methods
POPULATION | RATES | COITAL ACT | PANDEMIC INFLUENZA | DYNAMICS | MICROBIOLOGY | NETWORK STRUCTURE | EPIDEMIC | SPREAD | HIV-1 TRANSMISSION | BAYESIAN-INFERENCE | Communicable Diseases - transmission | Communicable Diseases - epidemiology | Humans | Influenza, Human - epidemiology | Mathematics | Influenza, Human - transmission | Models, Statistical | Host-Pathogen Interactions | Stochastic Processes | Disease Outbreaks | Epidemiologic Methods | Models, Biological | Ecosystem | Usage | Mathematical analysis | Communicable diseases | Analysis | Distribution | Epidemiology | Risk factors | Methods
Journal Article
Philosophical Transactions: Biological Sciences, ISSN 0962-8436, 8/2013, Volume 368, Issue 1623, pp. 1 - 14
The global incidence of poliomyelitis has dropped by more than 99 per cent since the governments of the world committed to eradication in 1988. One of the...
Immunization | Oral poliovirus vaccine | Poliomyelitis | Vaccination | Polio | Viruses | Children | Poliovirus | Immunity | Environmental surveillance
Immunization | Oral poliovirus vaccine | Poliomyelitis | Vaccination | Polio | Viruses | Children | Poliovirus | Immunity | Environmental surveillance
Journal Article
PLoS Pathogens, ISSN 1553-7366, 04/2012, Volume 8, Issue 4, p. e1002599
Inactivated poliovirus vaccine (IPV) may be used in mass vaccination campaigns during the final stages of polio eradication. It is also likely to be adopted by...
MICROBIOLOGY | EXCRETION | LIVE | CHILDREN | TRIAL | IMMUNIZATION | RESPONSES | TRANSMISSION | VIROLOGY | HOUSEHOLD CONTACTS | POLIOMYELITIS VIRUS | OUTBREAK | PARASITOLOGY | Poliovirus Vaccine, Oral - immunology | Virus Shedding - drug effects | Virus Shedding - immunology | Humans | Poliomyelitis - prevention & control | Poliomyelitis - immunology | Poliovirus Vaccine, Inactivated - immunology | Poliovirus Vaccine, Inactivated - pharmacology | Immunity, Mucosal - drug effects | Animals | Poliovirus - immunology | Poliomyelitis - virology | Poliovirus Vaccine, Oral - pharmacology | Immunology | Poliomyelitis vaccine | Physiological aspects | Virulence (Microbiology) | Research | Poliovirus | Health aspects | Confidence intervals | Infections | Vaccines | Poliomyelitis | Programming languages
MICROBIOLOGY | EXCRETION | LIVE | CHILDREN | TRIAL | IMMUNIZATION | RESPONSES | TRANSMISSION | VIROLOGY | HOUSEHOLD CONTACTS | POLIOMYELITIS VIRUS | OUTBREAK | PARASITOLOGY | Poliovirus Vaccine, Oral - immunology | Virus Shedding - drug effects | Virus Shedding - immunology | Humans | Poliomyelitis - prevention & control | Poliomyelitis - immunology | Poliovirus Vaccine, Inactivated - immunology | Poliovirus Vaccine, Inactivated - pharmacology | Immunity, Mucosal - drug effects | Animals | Poliovirus - immunology | Poliomyelitis - virology | Poliovirus Vaccine, Oral - pharmacology | Immunology | Poliomyelitis vaccine | Physiological aspects | Virulence (Microbiology) | Research | Poliovirus | Health aspects | Confidence intervals | Infections | Vaccines | Poliomyelitis | Programming languages
Journal Article
Philosophical Transactions: Biological Sciences, ISSN 0962-8436, 6/2015, Volume 370, Issue 1671, pp. 1 - 7
The reason for holding a meeting to discuss biological challenges to vaccines is simple: not all vaccines work equally well in all settings. This special issue...
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 03/2018, Volume 115, Issue 12, p. 3078
Nonpolio enteroviruses are diverse and common viruses that can circulate year-round but tend to peak in summer. Although most infections are asymptomatic, they...
Demography | Climate effects | Dew point | Climatic data | Viruses | Climate models | Infections | Disease control | Epidemiology | Seasonal variations | Enteroviruses | Demographics | Disease transmission | Poliomyelitis | Annual variations | Serotypes | Viral infections
Demography | Climate effects | Dew point | Climatic data | Viruses | Climate models | Infections | Disease control | Epidemiology | Seasonal variations | Enteroviruses | Demographics | Disease transmission | Poliomyelitis | Annual variations | Serotypes | Viral infections
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 8, pp. 864 - 865
[...]circulating vaccine-derived polioviruses are continuing to cause poliomyelitis in a few countries, a rare outcome associated with continued use of the...
Infectious Disease | EFFICACY | CONTROLLED-TRIAL | INFECTIOUS DISEASES | Poliovirus Vaccine, Oral - immunology | Antibody Formation - immunology | Poliovirus - immunology | Humans | Antibodies, Viral - immunology | Poliomyelitis - prevention & control | Poliomyelitis - immunology | Poliovirus Vaccine, Oral - administration & dosage | Vaccines | Clinical trials | Poliomyelitis | Regulatory approval
Infectious Disease | EFFICACY | CONTROLLED-TRIAL | INFECTIOUS DISEASES | Poliovirus Vaccine, Oral - immunology | Antibody Formation - immunology | Poliovirus - immunology | Humans | Antibodies, Viral - immunology | Poliomyelitis - prevention & control | Poliomyelitis - immunology | Poliovirus Vaccine, Oral - administration & dosage | Vaccines | Clinical trials | Poliomyelitis | Regulatory approval
Journal Article
Science, ISSN 0036-8075, 6/2009, Volume 324, Issue 5934, pp. 1557 - 1561
A novel influenza A (H1N1) virus has spread rapidly across the globe. Judging its pandemic potential is difficult with limited data, but nevertheless essential...
Epidemics | Pandemics | Disease models | Influenza A virus | Surveillance | Analytical estimating | Travelers | Death | Viruses | Reports | Infections | MORTALITY | IMPACT | TRANSMISSIBILITY | MULTIDISCIPLINARY SCIENCES | STRATEGIES | Travel | Global Health | Disease Outbreaks | Mexico - epidemiology | Humans | Influenza A Virus, H1N1 Subtype | Influenza, Human - mortality | Molecular Sequence Data | Influenza, Human - epidemiology | Influenza, Human - virology | Influenza, Human - transmission | Disease transmission | Research | Statistics | Swine influenza | Distribution
Epidemics | Pandemics | Disease models | Influenza A virus | Surveillance | Analytical estimating | Travelers | Death | Viruses | Reports | Infections | MORTALITY | IMPACT | TRANSMISSIBILITY | MULTIDISCIPLINARY SCIENCES | STRATEGIES | Travel | Global Health | Disease Outbreaks | Mexico - epidemiology | Humans | Influenza A Virus, H1N1 Subtype | Influenza, Human - mortality | Molecular Sequence Data | Influenza, Human - epidemiology | Influenza, Human - virology | Influenza, Human - transmission | Disease transmission | Research | Statistics | Swine influenza | Distribution
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 11/2013, Volume 178, Issue 10, p. 1579
The "endgame" for worldwide poliomyelitis eradication will entail eventual cessation of the use of oral poliovirus vaccine (OPV) in all countries to prevent...
Epidemics | Immunization | Disease transmission | Poliomyelitis | Vaccines
Epidemics | Immunization | Disease transmission | Poliomyelitis | Vaccines
Journal Article
PLoS Neglected Tropical Diseases, ISSN 1935-2727, 04/2016, Volume 10, Issue 4, p. e0004616
Background Typhoid is an important public health challenge for India, especially with the spread of antimicrobial resistance. The decision about whether to...
TRIAL | COUNTRIES | CONJUGATE VACCINE | EFFICACY | TY21A | PREVENTION | VI CAPSULAR POLYSACCHARIDE | SALMONELLA-TYPHI | PARASITOLOGY | TROPICAL MEDICINE | FEVER | Prevalence | Age Factors | Typhoid Fever - epidemiology | Humans | Middle Aged | Child, Preschool | India - epidemiology | Infant | Paratyphoid Fever - epidemiology | Topography, Medical | Incidence | Young Adult | Adolescent | Aged, 80 and over | Adult | Aged | Child | Infant, Newborn | Cohort Studies | Drug resistance in microorganisms | Care and treatment | Antibiotics | Analysis | Typhoid fever | Infants | Dosage and administration | Management | Drug therapy | Health aspects | Public health | Studies | Trends | Vaccines | Typhoid | Mortality
TRIAL | COUNTRIES | CONJUGATE VACCINE | EFFICACY | TY21A | PREVENTION | VI CAPSULAR POLYSACCHARIDE | SALMONELLA-TYPHI | PARASITOLOGY | TROPICAL MEDICINE | FEVER | Prevalence | Age Factors | Typhoid Fever - epidemiology | Humans | Middle Aged | Child, Preschool | India - epidemiology | Infant | Paratyphoid Fever - epidemiology | Topography, Medical | Incidence | Young Adult | Adolescent | Aged, 80 and over | Adult | Aged | Child | Infant, Newborn | Cohort Studies | Drug resistance in microorganisms | Care and treatment | Antibiotics | Analysis | Typhoid fever | Infants | Dosage and administration | Management | Drug therapy | Health aspects | Public health | Studies | Trends | Vaccines | Typhoid | Mortality
Journal Article
Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9953, pp. 1505 - 1512
Summary Background Intestinal immunity induced by oral poliovirus vaccine (OPV) is imperfect and wanes with time, permitting transmission of infection by...
Internal Medicine | WILD-TYPE | IMMUNIZATION | RESPONSES | MEDICINE, GENERAL & INTERNAL | IMMUNOGENICITY | OUTBREAKS | MUCOSAL IMMUNITY | INFECTION | SILENT CIRCULATION | INDIA | Poliovirus Vaccine, Inactivated - administration & dosage | Virus Shedding - immunology | Humans | Child, Preschool | Immunization, Secondary - methods | Infant | Male | Poliomyelitis - prevention & control | Treatment Outcome | Poliomyelitis - immunology | Injections, Intramuscular | Poliovirus Vaccine, Oral - administration & dosage | Antibodies, Viral - blood | Intestines - immunology | Vaccination - methods | Poliovirus - immunology | Female | Studies | Antigens | Poliomyelitis | Vaccines | Drug dosages | Age | Children & youth
Internal Medicine | WILD-TYPE | IMMUNIZATION | RESPONSES | MEDICINE, GENERAL & INTERNAL | IMMUNOGENICITY | OUTBREAKS | MUCOSAL IMMUNITY | INFECTION | SILENT CIRCULATION | INDIA | Poliovirus Vaccine, Inactivated - administration & dosage | Virus Shedding - immunology | Humans | Child, Preschool | Immunization, Secondary - methods | Infant | Male | Poliomyelitis - prevention & control | Treatment Outcome | Poliomyelitis - immunology | Injections, Intramuscular | Poliovirus Vaccine, Oral - administration & dosage | Antibodies, Viral - blood | Intestines - immunology | Vaccination - methods | Poliovirus - immunology | Female | Studies | Antigens | Poliomyelitis | Vaccines | Drug dosages | Age | Children & youth
Journal Article
Science, ISSN 0036-8075, 08/2014, Volume 345, Issue 6199, pp. 922 - 925
Inactivated poliovirus vaccine (IPV) is efficacious against paralytic disease, but its effect on mucosal immunity is debated. We assessed the efficacy of IPV...
TRIAL | INTESTINAL IMMUNITY | IMMUNOGENICITY | MUCOSAL IMMUNITY | POLIOMYELITIS | MULTIDISCIPLINARY SCIENCES | MONOVALENT | STRATEGIES | CHILDREN | Pharmaceutical research | Dosage and administration | Research | Poliomyelitis vaccine | Drug interactions | Disease prevention | Vaccines | Poliomyelitis | Public health | Shedding | Effectiveness | Viruses | Attenuation | Children | Patients | Immunity
TRIAL | INTESTINAL IMMUNITY | IMMUNOGENICITY | MUCOSAL IMMUNITY | POLIOMYELITIS | MULTIDISCIPLINARY SCIENCES | MONOVALENT | STRATEGIES | CHILDREN | Pharmaceutical research | Dosage and administration | Research | Poliomyelitis vaccine | Drug interactions | Disease prevention | Vaccines | Poliomyelitis | Public health | Shedding | Effectiveness | Viruses | Attenuation | Children | Patients | Immunity
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2018, Volume 67, Issue suppl_1, pp. S1 - S3
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 07/2014, Volume 111, Issue 29, p. 10604
As polio eradication inches closer, the absence of poliovirus circulation in most of the world and imperfect vaccination coverage are resulting in immunity...
Immunization | Disease transmission | Time series | Viruses | Mathematical models | Maximum likelihood method
Immunization | Disease transmission | Time series | Viruses | Mathematical models | Maximum likelihood method
Journal Article
Science, ISSN 0036-8075, 11/2006, Volume 314, Issue 5802, pp. 1150 - 1153
The feasibility of global polio eradication is being questioned as a result of continued transmission in a few localities that act as sources for outbreaks...
Disease transmission | Oral poliovirus vaccine | Vaccination | Polio | Viruses | Reports | Infections | Children | Dosage | Poliovirus | Population density | POPULATION | TRIVALENT | IMMUNOGENICITY | DIARRHEA | EFFICACY | POLIOMYELITIS | MULTIDISCIPLINARY SCIENCES | VACCINE | ERADICATION | DEVELOPING-COUNTRIES | BRAZIL | Poliovirus Vaccine, Oral - chemistry | Dose-Response Relationship, Immunologic | Humans | Population Density | Sanitation | Immunization Programs | India - epidemiology | Poliomyelitis - epidemiology | Disease Outbreaks - prevention & control | Poliomyelitis - prevention & control | Poliovirus Vaccine, Oral - administration & dosage | Child | Prevention | Poliomyelitis | Causes of | Vaccines | Health aspects | Risk factors
Disease transmission | Oral poliovirus vaccine | Vaccination | Polio | Viruses | Reports | Infections | Children | Dosage | Poliovirus | Population density | POPULATION | TRIVALENT | IMMUNOGENICITY | DIARRHEA | EFFICACY | POLIOMYELITIS | MULTIDISCIPLINARY SCIENCES | VACCINE | ERADICATION | DEVELOPING-COUNTRIES | BRAZIL | Poliovirus Vaccine, Oral - chemistry | Dose-Response Relationship, Immunologic | Humans | Population Density | Sanitation | Immunization Programs | India - epidemiology | Poliomyelitis - epidemiology | Disease Outbreaks - prevention & control | Poliomyelitis - prevention & control | Poliovirus Vaccine, Oral - administration & dosage | Child | Prevention | Poliomyelitis | Causes of | Vaccines | Health aspects | Risk factors
Journal Article
Ecology, ISSN 0012-9658, 08/2013, Volume 94, Issue 8, p. 1795
Amphibian chytridiomycosis, caused by the chytrid fungus Batrachochy